Ambroise Marçais

2.2k total citations
53 papers, 725 citations indexed

About

Ambroise Marçais is a scholar working on Immunology, Ecology, Evolution, Behavior and Systematics and Agronomy and Crop Science. According to data from OpenAlex, Ambroise Marçais has authored 53 papers receiving a total of 725 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Immunology, 20 papers in Ecology, Evolution, Behavior and Systematics and 18 papers in Agronomy and Crop Science. Recurrent topics in Ambroise Marçais's work include T-cell and Retrovirus Studies (27 papers), Vector-Borne Animal Diseases (20 papers) and Animal Disease Management and Epidemiology (18 papers). Ambroise Marçais is often cited by papers focused on T-cell and Retrovirus Studies (27 papers), Vector-Borne Animal Diseases (20 papers) and Animal Disease Management and Epidemiology (18 papers). Ambroise Marçais collaborates with scholars based in France, Lebanon and United Kingdom. Ambroise Marçais's co-authors include Olivier Hermine, Ali Bazarbachi, Felipe Suárez, David Sibon, Rihab Nasr, Vincent Hahaut, Anne Van den Broeke, Keith Durkin, Laurent Frenzel and Michel Georges and has published in prestigious journals such as Nature Communications, Blood and Genome biology.

In The Last Decade

Ambroise Marçais

49 papers receiving 717 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ambroise Marçais France 16 453 239 227 181 146 53 725
Youichi Tatsumi Japan 7 360 0.8× 94 0.4× 111 0.5× 67 0.4× 236 1.6× 15 594
Hiroo Katsuya Japan 14 242 0.5× 120 0.5× 136 0.6× 38 0.2× 111 0.8× 57 536
Kenji Shirono Japan 12 284 0.6× 97 0.4× 112 0.5× 108 0.6× 56 0.4× 25 516
Takeaki Tomoyose Japan 13 316 0.7× 132 0.6× 163 0.7× 23 0.1× 59 0.4× 37 561
Norimasa Yasuda Japan 11 379 0.8× 31 0.1× 50 0.2× 180 1.0× 126 0.9× 25 676
T Amagasaki Japan 15 647 1.4× 470 2.0× 487 2.1× 29 0.2× 75 0.5× 34 785
Masateru Kohakura Japan 6 602 1.3× 481 2.0× 445 2.0× 38 0.2× 41 0.3× 6 711
Raffaella Trovato Italy 16 275 0.6× 182 0.8× 179 0.8× 32 0.2× 594 4.1× 24 975
Aiko‐Konno Shirakawa Japan 11 432 1.0× 63 0.3× 53 0.2× 14 0.1× 171 1.2× 14 591
Mitsutoshi Tara Japan 14 1.4k 3.1× 867 3.6× 962 4.2× 27 0.1× 119 0.8× 19 1.5k

Countries citing papers authored by Ambroise Marçais

Since Specialization
Citations

This map shows the geographic impact of Ambroise Marçais's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ambroise Marçais with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ambroise Marçais more than expected).

Fields of papers citing papers by Ambroise Marçais

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ambroise Marçais. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ambroise Marçais. The network helps show where Ambroise Marçais may publish in the future.

Co-authorship network of co-authors of Ambroise Marçais

This figure shows the co-authorship network connecting the top 25 collaborators of Ambroise Marçais. A scholar is included among the top collaborators of Ambroise Marçais based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ambroise Marçais. Ambroise Marçais is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bazarbachi, Ali, Ambroise Marçais, Arian Laurence, et al.. (2026). Outcomes of patients with HTLV-1 adult T-cell leukemia/lymphoma (ATLL) after allogeneic SCT: results of the EBMT LWP. Bone Marrow Transplantation. 61(3). 341–346.
2.
Andrieu, Guillaume P., Mathieu Simonin, Aurélie Cabannes‐Hamy, et al.. (2025). A metabolic synthetic lethality of phosphoinositide 3-kinase-driven cancer. Nature Communications. 16(1). 2191–2191. 2 indexed citations
3.
4.
Tortevoye, Patricia, Gabriel Carles, Jean‐Pierre Droz, et al.. (2025). Adult T‐cell leukemia/lymphoma in French Guiana (1990–2019): Epidemiology, clinical features, and HTLV ‐1 genetic diversity in the two main ethnic populations. International Journal of Cancer. 158(6). 1528–1540. 1 indexed citations
5.
López, Patricia, Ali Bazarbachi, Ambroise Marçais, et al.. (2024). Outcome of Patients with HTLV-1 Adult T-Cell Leukemia/Lymphoma (ATL) after Allogeneic SCT: Results of the EBMT LWP. Blood. 144(Supplement 1). 4950–4950.
6.
Alsibai, Kinan Drak, Mathieu Nacher, Antoine Gessain, et al.. (2023). Adult T-cell leukemia and lymphoma in French Guiana: a retrospective analysis with real-life data from 2009 to 2019. The Lancet Regional Health - Americas. 21. 100492–100492. 7 indexed citations
7.
Beauvais, David, Anne Thiébaut, Sophie Alain, et al.. (2022). Effective Letermovir Prophylaxis of CMV infection post allogeneic hematopoietic cell transplantation: Results from the French temporary authorization of use compassionate program. Journal of Clinical Virology. 148. 105106–105106. 12 indexed citations
8.
Hajj, Hiba El, Rita Hleihel, Marwan El Sabban, et al.. (2021). Loss of interleukin-10 activates innate immunity to eradicate adult T-cell leukemia-initiating cells. Haematologica. 106(5). 1443–1456. 11 indexed citations
9.
Bellon, Marcia, Izabela Bialuk, Veronica Galli, et al.. (2021). Germinal epimutation of Fragile Histidine Triad (FHIT) gene is associated with progression to acute and chronic adult T-cell leukemia diseases. Molecular Cancer. 20(1). 86–86. 9 indexed citations
10.
Guéry, Romain, Felipe Suárez, Fanny Lanternier, et al.. (2021). Poor outcome and high prevalence of invasive fungal infections in patients with adult T-cell leukemia/lymphoma exposed to zidovudine and interferon alfa. Annals of Hematology. 100(11). 2813–2824. 12 indexed citations
11.
Robin, Marie, Thomas Rémen, Amandine Luc, et al.. (2021). On Behalf of the SFGM-TC: Retrospective Comparison of Reduced and Higher Intensity Conditioning for High-Risk Myelodysplastic Syndrome Treated With Allogeneic Stem-Cell Transplantation. Clinical Lymphoma Myeloma & Leukemia. 22(1). 34–43. 3 indexed citations
12.
Artesi, Maria, Vincent Hahaut, Ambroise Marçais, et al.. (2021). PCIP-seq: simultaneous sequencing of integrated viral genomes and their insertion sites with long reads. Genome biology. 22(1). 97–97. 29 indexed citations
13.
Marçais, Ambroise, Ludovic Lhermitte, Maria Artesi, et al.. (2020). Targeted deep sequencing reveals clonal and subclonal mutational signatures in Adult T-cell leukemia/lymphoma and defines an unfavorable indolent subtype. Leukemia. 35(3). 764–776. 21 indexed citations
14.
Manceau, Sandra, Jean‐Sébastien Diana, Laure Joseph, et al.. (2020). Vascular access for optimal hematopoietic stem cell collection. Journal of Clinical Apheresis. 36(1). 12–19. 9 indexed citations
15.
Marçais, Ambroise, et al.. (2020). Maternal ABVD chemotherapy for Hodgkin lymphoma in a dichorionic diamniotic pregnancy: a case report. BMC Pregnancy and Childbirth. 20(1). 231–231. 9 indexed citations
16.
Macchi, Beatrice, Emanuela Balestrieri, Sandro Grelli, et al.. (2017). Quantification of HTLV-1 reverse transcriptase activity in ATL patients treated with zidovudine and interferon-α. Blood Advances. 1(12). 748–752. 24 indexed citations
17.
Rosewick, Nicolas, Keith Durkin, Maria Artesi, et al.. (2017). Cis-perturbation of cancer drivers by the HTLV-1/BLV proviruses is an early determinant of leukemogenesis. Nature Communications. 8(1). 15264–15264. 73 indexed citations
18.
Sibon, David, Franck Morschhauser, Matthieu Resche‐Rigon, et al.. (2015). Single or tandem autologous stem-cell transplantation for first-relapsed or refractory Hodgkin lymphoma: 10-year follow-up of the prospective H96 trial by the LYSA/SFGM-TC study group. Haematologica. 101(4). 474–481. 28 indexed citations
19.
Cornillon, Jérôme, Christine Decanter, M. Couturier, et al.. (2013). Suivi et prise en charge des troubles endocriniens en post-greffe de cellules souches hématopoïétiques : insuffisance gonadique et fertilité. Pathologie Biologie. 61(4). 164–167. 7 indexed citations
20.
Frenzel, Laurent, Bertrand Moura, Ambroise Marçais, Hugo Chapdelaine, & Olivier Hermine. (2013). HTLV-1-associated arthropathy treated with anti-TNF-alpha agent. Joint Bone Spine. 81(4). 360–361. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Youichi Tatsumi Breakdown of academic impact, for papers by Hiroo Katsuya Breakdown of academic impact, for papers by Kenji Shirono Breakdown of academic impact, for papers by Takeaki Tomoyose Breakdown of academic impact, for papers by Norimasa Yasuda Breakdown of academic impact, for papers by T Amagasaki Breakdown of academic impact, for papers by Masateru Kohakura Breakdown of academic impact, for papers by Raffaella Trovato Breakdown of academic impact, for papers by Aiko‐Konno Shirakawa Breakdown of academic impact, for papers by Mitsutoshi Tara
Rankless by CCL
2026